S&P 500   4,651.64 (+1.24%)
DOW   35,097.40 (+0.57%)
QQQ   398.31 (+1.82%)
AAPL   160.07 (+2.08%)
MSFT   337.15 (+2.27%)
FB   337.46 (+1.30%)
GOOGL   2,900.15 (+1.99%)
AMZN   3,578.19 (+2.10%)
TSLA   1,132.11 (+4.64%)
NVDA   327.48 (+3.95%)
BABA   131.69 (-1.24%)
NIO   39.80 (-0.48%)
CGC   11.04 (-5.56%)
AMD   158.91 (+2.65%)
GE   97.35 (-0.50%)
MU   84.52 (+1.32%)
T   23.92 (-1.24%)
F   19.67 (-0.41%)
DIS   144.87 (-2.19%)
ACB   6.42 (-5.45%)
AMC   36.27 (-3.61%)
PFE   53.96 (-0.07%)
BA   196.50 (-1.36%)
S&P 500   4,651.64 (+1.24%)
DOW   35,097.40 (+0.57%)
QQQ   398.31 (+1.82%)
AAPL   160.07 (+2.08%)
MSFT   337.15 (+2.27%)
FB   337.46 (+1.30%)
GOOGL   2,900.15 (+1.99%)
AMZN   3,578.19 (+2.10%)
TSLA   1,132.11 (+4.64%)
NVDA   327.48 (+3.95%)
BABA   131.69 (-1.24%)
NIO   39.80 (-0.48%)
CGC   11.04 (-5.56%)
AMD   158.91 (+2.65%)
GE   97.35 (-0.50%)
MU   84.52 (+1.32%)
T   23.92 (-1.24%)
F   19.67 (-0.41%)
DIS   144.87 (-2.19%)
ACB   6.42 (-5.45%)
AMC   36.27 (-3.61%)
PFE   53.96 (-0.07%)
BA   196.50 (-1.36%)
S&P 500   4,651.64 (+1.24%)
DOW   35,097.40 (+0.57%)
QQQ   398.31 (+1.82%)
AAPL   160.07 (+2.08%)
MSFT   337.15 (+2.27%)
FB   337.46 (+1.30%)
GOOGL   2,900.15 (+1.99%)
AMZN   3,578.19 (+2.10%)
TSLA   1,132.11 (+4.64%)
NVDA   327.48 (+3.95%)
BABA   131.69 (-1.24%)
NIO   39.80 (-0.48%)
CGC   11.04 (-5.56%)
AMD   158.91 (+2.65%)
GE   97.35 (-0.50%)
MU   84.52 (+1.32%)
T   23.92 (-1.24%)
F   19.67 (-0.41%)
DIS   144.87 (-2.19%)
ACB   6.42 (-5.45%)
AMC   36.27 (-3.61%)
PFE   53.96 (-0.07%)
BA   196.50 (-1.36%)
S&P 500   4,651.64 (+1.24%)
DOW   35,097.40 (+0.57%)
QQQ   398.31 (+1.82%)
AAPL   160.07 (+2.08%)
MSFT   337.15 (+2.27%)
FB   337.46 (+1.30%)
GOOGL   2,900.15 (+1.99%)
AMZN   3,578.19 (+2.10%)
TSLA   1,132.11 (+4.64%)
NVDA   327.48 (+3.95%)
BABA   131.69 (-1.24%)
NIO   39.80 (-0.48%)
CGC   11.04 (-5.56%)
AMD   158.91 (+2.65%)
GE   97.35 (-0.50%)
MU   84.52 (+1.32%)
T   23.92 (-1.24%)
F   19.67 (-0.41%)
DIS   144.87 (-2.19%)
ACB   6.42 (-5.45%)
AMC   36.27 (-3.61%)
PFE   53.96 (-0.07%)
BA   196.50 (-1.36%)
NASDAQ:NMTR

9 Meters Biopharma Insider Trades

$1.03
-0.02 (-1.43%)
(As of 11/29/2021 11:46 AM ET)
Add
Compare
Today's Range
$1.03
$1.05
50-Day Range
$1.04
$1.41
52-Week Range
$0.68
$2.26
Volume
17,157 shs
Average Volume
5.45 million shs
Market Capitalization
$264.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.24

9 Meters Biopharma (NASDAQ:NMTR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.80%

Number Of
Insiders Buying
(Last 12 Months)
4

Amount Of
Insider Buying
(Last 12 Months)
$716.27 K

Number Of
Insiders Selling
(Last 12 Months)
1

Amount Of
Insider Selling
(Last 12 Months)
$20.49 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get NMTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling 9 Meters Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


9 Meters Biopharma (NASDAQ NMTR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021John TemperatoCEOBuy50,000$1.05$52,500.00  
11/18/2021Mark A SirgoDirectorBuy20,000$1.06$21,200.00  
9/14/2021Edward J SitarCFOBuy15,000$1.22$18,300.00  
9/7/2021Mark A SirgoDirectorBuy73,529$1.36$99,999.44  
8/24/2021Michael T ConstantinoDirectorBuy18,000$1.14$20,520.00  
8/20/2021Mark A SirgoDirectorBuy25,000$1.10$27,500.00  
8/18/2021John TemperatoCEOBuy25,000$1.05$26,250.001,102,522  
6/25/2021Israel Gp Ltd. OrbimedMajor ShareholderSell15,989,876$1.21$19,347,749.96  
6/23/2021Israel Gp Ltd. OrbimedMajor ShareholderSell841,650$1.36$1,144,644.00  
4/5/2021Edward J SitarCFOBuy50,000$1.00$50,000.00179,338  
4/5/2021John TemperatoCEOBuy100,000$1.00$100,000.001,077,522  
4/5/2021Mark A SirgoDirectorBuy300,000$1.00$300,000.001,074,066  
9/10/2020Mark A SirgoDirectorBuy50,000$0.60$30,000.00461,784  
8/21/2020John TemperatoCEOBuy70,000$0.69$48,300.00615,496  
8/17/2020John TemperatoCEOBuy35,000$0.57$19,950.00545,496  
8/17/2020Mark A SirgoDirectorBuy100,000$0.56$56,000.00411,784  
6/15/2020John TemperatoCEOBuy10,000$0.60$6,000.00
(Data available from 1/1/2013 forward)












9 Meters Biopharma (NASDAQ:NMTR) Insider Trade Frequently Asked Questions

Who is on 9 Meters Biopharma's Insider Roster?

The list of insiders at 9 Meters Biopharma includes Edward J Sitar, Israel Gp Ltd. Orbimed, John Temperato, Mark A Sirgo, and Michael T Constantino.Learn more on NMTR's insiders

What percentage of 9 Meters Biopharma stock is owned by insiders?

2.80% of 9 Meters Biopharma stock is owned by insiders. Learn more on NMTR's insider holdings

Which 9 Meters Biopharma insiders have been buying company stock?

The following insiders have purchased 9 Meters Biopharma stock in the last 24 months: Edward J Sitar ($68,300.00), John Temperato ($253,000.00), Mark A Sirgo ($534,699.44), and Michael T Constantino ($20,520.00).

How much insider buying is happening at 9 Meters Biopharma?

Insiders have purchased a total of 941,529 9 Meters Biopharma shares in the last 24 months for a total of $876,519.44 bought.

Which 9 Meters Biopharma insiders have been selling company stock?

The following insider sold 9 Meters Biopharma stock in the last 24 months: Israel Gp Ltd. Orbimed ($20,492,393.96).

How much insider selling is happening at 9 Meters Biopharma?

Insiders have sold a total of 16,831,526 9 Meters Biopharma shares in the last 24 months for a total of $20,492,393.96 sold.

This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.